The importance of being dehydroepiandrosterone sulfate (in the blood of primates): A longer and healthier life?

Biochemical Pharmacology

Volumn 57, Issue 4, 1999, Pages 329-346

  Roberts, Eugene ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Adrenal cortical oxygenation; Aging; Arteriosclerosis; Dehydroepiandrosterone sulfate; Endothelial cells; Serum steroids; Testosterone transport

Indexed keywords

17 HYDROXYPREGNENOLONE; ALBUMIN; ALDOSTERONE; ANDROSTENEDIONE; CHOLESTEROL; ESTRADIOL; HYDROCORTISONE; HYDROXYPROGESTERONE; PRASTERONE; PRASTERONE SULFATE; PREGNENOLONE; PREGNENOLONE SULFATE; PROGESTERONE; TESTOSTERONE;

ADRENAL CORTEX; AGING; ATHEROSCLEROSIS; BRAIN BLOOD FLOW; ENDOTHELIUM CELL; HUMAN; MENTAL HEALTH; NONHUMAN; PRIMATE; PRIORITY JOURNAL; REVIEW; STEROID BLOOD LEVEL;

EID: 0032928853     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00246-9     Document Type: Article

References (84)

1. Orentreich N., Brind J.L., Rizer R.L., Vogelman J.H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 59:1984;551-555.
2. Parker LN, Adrenal Androgens in Clinical Medicine. Academic Press, New York, 1989.
3. Sonka J. Dehydroepiandrosterone Metabolic effects . Acta Univ Carol [Med] (Praha). 71:1976;1-171.
4. Hornsby P.J. Biosynthesis of DHEAS by the human adrenal cortex and its age-related decline. Ann NY Acad Sci. 774:1995;29-46.
5. Baulieu E.-E. Dehydroepiandrosterone (DHEA) A fountain of youth? J Clin Endocrinol Metab. 81:1996;3147-3151.
6. Bellino F.L., Daynes R.A., Hornsby P.J., Lavrin D.H., Nestler J.E. Dehydroepiandrosterone (DHEA) and Aging. 1995;New York Academy of Sciences, New York.
7. Kalimi M., Regelson W. The Biologic Role of Dehydroepiandrosterone (DHEA). 1990;Walter de Gruyter, Berlin.
8. Morley J.E., Kaiser F., Raum W.J., Perry H.M. III, Flood J.F., Jensen J., Silver A.J., Roberts E. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male Progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone . Proc Natl Acad Sci USA. 94:1997;7537-7542.
9. Korenman S.G., Morley J.E., Mooradian A.D., Davis S.S., Kaiser F.E., Silver A.J., Viosca S.P., Garza D. Secondary hypogonadism in older men Its relation to impotence . J Clin Endocrinol Metab. 71:1990;963-969.
10. Manni A., Pardridge W.M., Cefalu W., Nisula B.C., Bardin C.W., Santner S.J., Santen R.J. Bioavailability of albumin-bound testosterone. J Clin Endocrinol Metab. 61:1985;705-710.
11. Nankin H.R., Calkins J.H. Decreased bioavailable testosterone in aging normal and impotent men. J Clin Endocrinol Metab. 63:1986;1418-1420.
12. Vermeulen A., Verdonck L., Van der Straeten M., Orie N. Capacity of the testosterone-binding globulin in human plasma and influence of specific binding of testosterone on its metabolic clearance rate. J Clin Endocrinol. 29:1969;1470-1480.
13. Cekan S.Z., Xing S., Ritzen M. On the binding of steroid sulfates to albumin. Experientia. 40:1984;949-951.
14. Fischer M.J.E., Bos O.J.M., van der Linden R.F., Wilting J., Janssen L.H.M. Steroid binding to human serum albumin and fragments thereof Role of protein conformation and fatty acid content . Biochem Pharmacol. 45:1993;2411-2416.
15. Peters T Jr, All About Albumin. Academic Press, San Diego, 1996.
16. Romeu A.M., Martino E.E., Stoppani A.O.M. Structural requirements for the action of steroids as quenchers of albumin fluorescence. Biochim Biophys Acta. 409:1975;376-386.
17. Romeu A.M., Martino E.E., Stoppani A.O.M. Structural requirements for steroid binding and quenching of albumin fluorescence in bovine plasma albumin. Biochim Biophys Acta. 439:1976;175-193.
18. Wang D.Y., Bulbrook R.D. Binding of the sulphate esters of dehydroepiandrosterone, testosterone, 17-acetoxypregnenolone and pregnenolone in the plasma of man, rabbit and rat. J Endocrinol. 39:1967;405-413.
19. Frye C.A., Van Keuren K.R., Rao P.N., Erskine M.S. Progesterone and 3α-androstanediol conjugated to bovine serum albumin affects estrous behavior when applied to the MBH and POA. Behav Neurosci. 110:1996;603-612.
20. A receptor. Mechanism of action and physiological significance . Prog Neurobiol. 38:1992;379-395.
21. Roberts E., Matthysse S. Neurochemistry At the crossroads of neurobiology . Annu Rev Biochem. 39:1970;777-820.
22. Dilman V.M. Ageing, metabolic immunodepression and carcinogenesis. Mech Ageing Dev. 8:1978;153-173.
23. 2 consumption with age. J Clin Invest. 53:1974;572-581.
24. Everitt A., Meites J. Aging and anti-aging effects of hormones. J Gerontol. 44:1989;B139-B147.
25. Regelson W., Loria R., Kalimi M. Hormonal intervention "buffer hormones" or "state dependency." The role of dehydroepiandrosterone (DHEA), thyroid hormone, estrogen and hypophysectomy in aging . Ann NY Acad Sci. 521:1988;260-273.
26. Scheller R.H., Jackson J.F., McAllister L.B., Rothman B.S., Mayeri E., Axel R. A single gene encodes multiple neuropeptides mediating a stereotyped behavior. Cell. 32:1983;7-22.
27. Birren JE, Butler RN, Greenhouse SW, Sokoloff L and Yarrow MR (Eds.), Human Aging: A Biological Behavioral Study, Public Health Service Publ. No. 986. U.S. Government Printing Office, Washington, DC, 1963.
28. Sokoloff L, Cerebral circulatory and metabolic changes associated with aging. In: Cerebrovascular Disease, a publication of the Association for Research in Nervous and Mental Disease, vol. XLI, pp. 237-254. Williams & Wilkins, Baltimore, MD, 1966.
29. Globus M., Melamed E. Progressive age-related decrease in regional cerebral blood flow in healthy subjects. Isr J Med Sci. 21:1985;662-665.
30. Roberts E. Senile dementia of the Alzheimer's type A possible cerebrovascular origin and some therapeutic suggestions . Scheibel A.B., Wechsler A.F. The Biological Substrates of Alzheimer's Disease. 1986;241-266 Academic Press, Orlando, FL.
31. Dobbie J.W., Symington T. The human adrenal gland with special reference to the vasculature. J Endocrinol. 34:1966;479-489.
32. Bassett J.R., West S.H. Vascularization of the adrenal cortex Its possible involvement in the regulation of steroid hormone release . Microsc Res Tech. 36:1997;546-557.
33. Dhall U., Cowen T., Haven A.J., Burnstock G. Perivascular noradrenergic and peptide-containing nerves show different patterns of changes during development and ageing in the guinea-pig. J Auton Nerv Syst. 16:1986;109-126.
34. Vise W.M., Liss L., Yashon D., Hunt W.E. Astrocytic processes A route between vessels and neurons following blood-brain barrier injury . J Neuropathol Exp Neurol. 34:1975;324-334.
35. Scheibel A.B., Duong T., Tomiyasu U. Microvascular changes in Alzheimer's disease. Scheibel A.B., Wechsler A.F. The Biological Substrates of Alzheimer's Disease. 1986;177-192 Academic Press, Orlando, FL.
36. Issidorides M.R. Neuronal vascular relationships in the zona compacta of normal and Parkinsonian substantia nigra. Brain Res. 25:1971;289-299.
37. Harris A.B. Structural and chemical changes in experimental epileptic foci. Lockard J.S., Ward A.A. Jr. Epilepsy A Window to Brain Mechanisms . 1980;149-164 Raven Press, New York.
38. Isaacson R.L., Varner J.A., Jensen K.F. Toxin-induced blood vessel inclusions caused by the chronic administration of aluminum and sodium fluoride and their implications for dementia. Ann NY Acad Sci. 825:1997;152-166.
39. Epstein M.A., Packer R.J., Rorke L.B., Zimmerman R.A., Goldwein J.W., Sutton L.N., Schut L. Vascular malformation with radiation vasculopathy after treatment of chiasmatic/hypothalamic glioma. Cancer. 70:1992;887-893.
40. Dellmann H.-D., Carithers J. Development of neural lobe-like neurovascular contact regions after intrahypothalamic transection of the hypothalamo-neurohypophysial tract. Brain Res. 585:1992;19-27.
41. Hassler O. Vascular changes in senile brains A micro-angiographic study . Acta Neuropathol (Berl). 5:1965;40-53.
42. Ravens J.R. Vascular changes in the human senile brain. Adv Neurol. 20:1978;487-501.
43. Chang E., Harley C.B. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA. 92:1995;11190-11194.
44. Kay M.M.B. Band 3, the predominant transmembrane polypeptide, undergoes proteolytic degradation as cells age. Monogr Dev Biol. 17:1984;245-253.
45. Symington T, Functional Pathology of the Human Adrenal Gland. E & S Livingstone Ltd., Edinburgh, 1969.
46. Meeker A.K., Sommerfeld H.J., Coffey D.S. Telomerase is activated in the prostate and seminal vesicles of the castrated rat. Endocrinology. 137:1996;5743-5746.
47. Carr I. The human adrenal cortex at the time of death. J Pathol Bact. 78:1959;533-541.
48. Wolkersdörfer G.W., Ehrhart-Bornstein M., Brauer S., Marx C., Scherbaum W.A., Bornstein S.R. Differential regulation of apoptosis in the normal human adrenal gland. J Clin Endocrinol Metab. 81:1996;4129-4136.
49. Miller W.L. Molecular biology of steroid hormone synthesis. Endocr Rev. 9:1988;295-318.
50. Miller W.L., Auchus R.J., Geller D.H. The regulation of 17,20 lyase activity. Steroids. 62:1997;133-142.
51. Sapolsky R.M. Glucocorticoid toxicity in the hippocampus Reversal by supplementation with brain fuels . J Neurosci. 6:1986;2240-2244.
52. Rosolowsky L.J., Campbell W.B. Endothelial cells stimulate aldosterone release from bovine adrenal zona glomerulosa cells. Am J Physiol. 266:1994;E107-E117.
53. Yoneyama A., Kamiha Y., Kawaguchi M., Fujinami T. Effects of dehydroepiandrosterone on proliferation of human aortic smooth muscle cells. Life Sci. 60:1997;833-838.
54. Chabre O., Defaye G., Chambaz E.M. Oxygen availability as a regulatory factor of androgen synthesis by adrenocortical cells. Endocrinology. 132:1993;255-260.
55. Sakima N.T., Breslow M.J., Raff H., Traystman R.J. Lack of coupling between adrenal cortical metabolic activity and blood flow in anesthetized dogs. Am J Physiol. 261:1991;H410-H415.
56. Parker L., Eugene J., Farber D., Lifrak E., Lai M., Juler G. Dissociation of adrenal androgen and cortisol levels in acute stress. Horm Metab Res. 17:1985;209-212.
57. Parker L., Gral T., Perrigo V., Skowsky R. Decreased adrenal androgen sensitivity to ACTH during aging. Metabolism. 30:1981;601-604.
58. Parker L.N., Levin E.R., Lifrak E.T. Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab. 60:1985;947-952.
59. Parker L.N., Odell W.D. Control of adrenal androgen secretion. Endocr Rev. 1:1980;392-410.
60. Vermeulen A., Deslypere J.P., Schelfhout W., Verdonck L., Rubens R. Adrenocortical function in old age Response to acute adrenocorticotropin stimulation . J Clin Endocrinol Metab. 54:1982;187-191.
61. Munari-Silem Y., Lebrethon M.C., Morand I., Rousset B., Saez J.M. Gap junction-mediated cell-to-cell communication in bovine and human adrenal cells A process whereby cells increase their responsiveness to physiological corticotropin concentrations . J Clin Invest. 95:1995;1429-1439.
62. Xia Y., Wikberg J.E.S. Localization of ACTH receptor mRNA by in situ hybridization in mouse adrenal gland. Cell Tissue Res. 286:1996;63-68.
63. Spray D.C., Harris A.L., Bennett M.V.L. Gap junctional conductance is a simple and sensitive function of intracellular pH. Science. 211:1981;712-715.
64. Glass G.A., Gershon H., Gershon D. The effect of donor and cell age on several characteristics of rat erythrocytes. Exp Hematol. 11:1983;987-995.
65. Glass G.A., Gershon D., Gershon H. Some characteristics of the human erythrocyte as a function of donor and cell age. Exp Hematol. 13:1985;1122-1126.
66. Kalofoutis A., Paterakis S., Koutselinis A., Spanos V. Relationship between erythrocyte 2,3-diphosphoglycerate and age in a normal population. Clin Chem. 22:1976;1918-1919.
67. Purcell Y., Brozovic B. Red cell 2,3-diphosphoglycerate concentration in man decreases with age. Nature. 251:1974;511-512.
68. Sheiban E., Gershon H. Recognition and sequestration of young and old erythrocytes from young and elderly human donors In vitro studies . J Lab Clin Med. 121:1993;493-501.
69. Bornstein S.R., Gonzalez-Hernandez J.A., Ehrhart-Bornstein M., Adler G., Scherbaum W.A. Intimate contact of chromaffin and cortical cells within the human adrenal gland forms the cellular basis for important intraadrenal interactions. J Clin Endocrinol Metab. 78:1994;225-232.
70. Newcomer T.A., Rosenberg P.A., Aizenman E. TOPA quinone, a kainate-like agonist and excitotoxin, is generated by a catecholaminergic cell line. J Neurosci. 15:1995;3172-3177.
71. Brandt I., Mohammed A., Lyden A., Slanina P. Disposition of some sulphur-containing hexachlorobenzene (HCB) metabolites Affinity of methylsulphonylpentachlorobenzene for the gray matter of brain, the lungs and the adrenal zona reticularis . Acta Pharmacol Toxicol. 54:1984;352-360.
72. Alexanian R. Erythropoietin and erythropoiesis in anemic man following androgens. Blood. 33:1969;564-572.
73. Beran M., Spitzer G., Verma D.S. Testosterone and synthetic androgens improve the in vitro survival of human marrow progenitor cells in serum-free suspension cultures. J Lab Clin Med. 99:1982;247-253.
74. Fisher J.W., Samuels A.I., Malgor L.A. Androgens and erythropoiesis. Isr J Med Sci. 7:1971;892-900.
75. Levere R.D., Gordon A.S., Zanjani E.D., Kappas A. Stimulation of mammalian erythropoiesis by metabolites of steroid hormones. Trans Assoc Am Physicians. 83:1970;150-158.
76. Parker J.P., Beirne G.J., Desai J.N., Raich P.C., Shahidi N.T. Androgen-induced increase in red-cell 2,3-diphosphoglycerate. N Engl J Med. 287:1972;381-383.
77. Singer J.W., Adamson J.W. Steroids and hematopoiesis II. The effect of steroids on in vitro erythroid colony growth: Evidence for different target cells for different classes of steroids . J Cell Physiol. 88:1976;135-143.
78. Solomon L.R., Hendler E.D. Androgen therapy in haemodialyis patients II. Effects on red cell metabolism . Br J Haematol. 65:1987;223-230.
79. Wahr J.A., Trouwborst A., Spence R.K., Henny C.P., Cernaianu A.C., Graziano G.P., Tremper K.K., Flaim K.E., Keipert P.E., Faithfull N.S., Clymer J.J. A pilot study of the effects of a perflubron emulsion, AF 0104, on mixed venous oxygen tension in anesthetized surgical patients. Anesth Analg. 82:1996;103-107.
80. Khandelwal S.R., Randad R.S., Lin P.-S., Meng H., Pittman R.N., Kontos H.A., Choi S.C., Abraham D.J., Schmidt-Ullrich R. Enhanced oxygenation in vivo by allosteric inhibitors of hemoglobin saturation. Am J Physiol. 265:1993;H1450-H1453.
81. Morales A.J., Nolan J.J., Nelson J.C., Yen S.S.C. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab. 78:1994;1360-1367.
82. Roberts E., Fitten L.J. Serum steroid levels in two old men with Alzheimer's disease (AD) before, during, and after oral administration of dehydroepiandrosterone (DHEA) Pregnenolone synthesis may become rate-limiting in aging . Kalimi M., Regelson W. The Biological Role of Dehydroepiandrosterone (DHEA). 1990;43-63 Walter de Gruyter, Berlin.
83. Morley J.E., Perry H.M. III, Kaiser F.E., Kraenzle D., Jensen J., Houston K., Mattammal M., Perry H.M. Jr. Effects of testosterone replacement therapy in old hypogonadal males A preliminary study . J Am Geriatr Soc. 41:1993;149-152.
84. Hechter O., Grossman A., Chatterton R.T. Jr. Relationship of dehydroepiandrosterone and cortisol in disease. Med Hypotheses. 49:1997;85-91.